FREE Account Opening + No Clearing Fees
Loading...
December 6, 2016 - December 8, 2016

Laurus Labs IPO Latest News Today

Track all the latest updates and news of Laurus Labs IPO.

  1. Laurus Labs Standalone March 2024 Net Sales at Rs 1,414.52 crore, up 10.57% Y-o-Y

    April 26, 2024 10:14:00 AM

    Quarterly Net Profit at Rs. 121.32 crore in March 2024 up 18.62% from Rs. 102.28 crore in March 2023. EBITDA stands at Rs. 295.20 crore in March 2024 up 14.25% from Rs. 258.38 crore in March 2023.

    Published by : moneycontrol.com
  2. Laurus Labs Q4 earnings: Net profit slips 25%; stock ends lower

    April 25, 2024 2:56:25 PM

    Pharma firm Laurus Labs reported a 25 percent fall in net profit for the March 2024 quarter. Net profit slipped to Rs 76 crore in the March 2024 quarter from Rs 102 crore in the year-ago period. The ...

    Published by : Business Today on MSN
  3. Laurus Labs share price plunges 10% on disappointing Q3 earnings; Heres what brokerages say

    January 25, 2024 6:47:00 PM

    3 min read 25 Jan 2024, 10:47 AM IST Trade Now According to Rajesh Bhosale, Equity Technical and Derivative Analyst at Angel One, Laurus Labs stock prices have seen a gap-down opening and have ...

    Published by : Mint
  4. Laurus Labs Ltd (LAURUSLABS) Share Price

    April 25, 2024 3:30:00 AM

    Laurus Labs Ltd share price was up by 3.07% from the previous closing price of ?429.95. Who are peers of Laurus Labs Ltd? The peers of Laurus Labs Ltd are Sun Pharmaceuticals Industries Ltd ...

    Published by : Business Today
  5. Q4 results today: Tech Mahindra, Bajaj Finance, Mphasis, ACC, Nestle, and others to report Q4 results today; check list

    April 25, 2024 7:43:00 AM

    Tech Mahindra, Bajaj Finance, Nestle, Mphasis, ACC, Indusind Bank, Coromandel, and many others are set to announce their quarterly results.

    Published by : Hindustan Times on MSN
  6. LAURUS LABS

    April 10, 2024 2:47:00 AM

    The PE firm's other investments in the Indian healthcare sector include Meril Life Sciences, MedPlus, Laurus Labs, and Metropolis Healthcare. 2DG has been given emergency approval by the Drugs ...

    Published by : health.economictimes.indiatimes
  7. Q4 results today: Bajaj Finance, IndusInd Bank, Tech Mahindra among 38 companies to report Q4 earnings on April 25

    April 25, 2024 4:36:59 AM

    Bajaj Finance, Nestle India, Tech Mahindra, IndusInd Bank, Schaeffler India, ACC, MphasiS, Coromandel International, Laurus Labs, Cyient, TTML, Olectra Greentech, etc. will announce their Q4 results t ...

    Published by : Live Mint on MSN
  8. Astera Labs IPO will reveal how much investors want in on AI

    March 20, 2024 3:30:00 AM

    IPO watchers expect it to debut this week. Update: Astera Labs priced its IPO at $36 per share, above its raised range. More when it starts trading. For more, hit play below: While Reddit's IPO ...

    Published by : Yahoo
  9. Astera Labs IPO will reveal how much investors want in on AI

    March 20, 2024 3:30:00 AM

    IPO watchers expect it to debut this week. Update: Astera Labs priced its IPO at $36 per share, above its raised range. More when it starts trading. For more, hit play below: While Reddit's IPO could ...

    Published by : Yahoo Style Canada

Laurus Labs IPO Alerts

1. Laurus Labs Ltd IPO - Listing  Friday, December 16, 2016 7:47:13 AM

Laurus Labs IPO Listing Date

› Listing Date: Monday, December 19, 2016
› BSE Script Code: 540222
› NSE Symbol: LAURUSLABS
› Listing In: ‘B’ Group of Securities
› ISIN: INE947Q01010
› Issue Price: Rs. 428.00 Per Equity Share
› Face Value: Rs. 10.00 Per Equity Share

2. Laurus Labs Ltd IPO - Allotment  Thursday, December 15, 2016 7:40:07 AM

Laurus Labs Ltd IPO Allotment Status is now available online.

Laurus Labs Ltd is Hyderabad based pharmaceutical company engaged in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.

The Initial Public Offer of Laurus Labs subscribed 4.53 times (1.58 times in retail). Public Issue of Laurus Labs was closed for subscription on Dec 08, 2016.

3. Laurus Labs Ltd IPO - Close  Tuesday, December 6, 2016 8:06:53 AM

Laurus Labs Ltd IPO to open on Dec 06, 2016 and close for subscription on Dec 08, 2016. The price band for the issue has been fixed at Rs 426 at lower level and Rs 428 at upper level. The equity shares of the company to be list at BSE and NSE.

4. Lauras Labs Ltd IPO - Open  Tuesday, December 6, 2016 8:06:38 AM

Laurus Labs Ltd is entering in the capital markets with an initial public offering, Fresh Issue aggregating up to Rs 300.00 Cr and Offer for Sale of 24,107,440 Equity Shares of Rs 10. The price band for the issue has been fixed at Rs 426 at lower level and Rs 428 at upper level.

Laurus Labs Ltd is Hyderabad based pharmaceutical company. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.

The issue opens on Dec 06, 2016 and closes for subscription on Dec 08, 2016. The equity shares of the issue are proposed to be list on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Laurus Labs IPO News & Events FAQs

The Laurus Labs IPO is proposed to open on December 6, 2016. The IPO application ends on December 8, 2016.

Retail investors can apply in the retail or non-institutional investor category from December 6, 2016 to December 8, 2016. The Laurus Labs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Laurus Labs IPO will open for subscription on December 6, 2016. The public issue will close on December 8, 2016.